First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 122.9% of the 56,875 shares held after it.
No other insider sold within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $163.5K of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 106.9% of the 17,875 shares held after it.
No other insider sold within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $44.7K of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 127.8% of the 361,400 shares held after it.
No other insider sold within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $1.1M of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 24, 2021.
The trade is 77.4% of the 6,462 shares held after it.
No other insider bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Interim CEO and CFO Kennedy Thomas Ronan bought about $10.5K of YCBD on May 3, 2023, the largest insider purchase at the company since 2021; 8 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 7,400 shares held after it.
No other insider bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO & COO Kennedy Thomas Ronan bought about $15.1K of YCBD on Aug 24, 2021, the largest insider purchase at the company on our record; 8 funds added in the latest 13F quarter.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$20.9M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM YCBD
FY Sep 2025
$19.2M
FY Sep 2024
$19.9M
FY Sep 2023
$25.1M
FY Sep 2022
$37.1M
FY Sep 2021
n/a
Jun 2026
$5.6M
Mar 2026
$5.6M
Dec 2025
$5.0M
Sep 2025
$4.7M
Jun 2025
$4.6M
Mar 2025
$4.7M
Dec 2024
$5.1M
Sep 2024
$4.6M
At each fiscal year end
Single quarter
Net margin, TTM
-13.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM YCBD
FY Sep 2025
-10.6%
FY Sep 2024
-18.6%
FY Sep 2023
-91.6%
FY Sep 2022
-188.8%
FY Sep 2021
n/a
Jun 2026
-20.3%
Mar 2026
-14.1%
Dec 2025
-5.6%
Sep 2025
-14.4%
Jun 2025
-19.4%
Mar 2025
-10.1%
Dec 2024
+0.3%
Sep 2024
-3.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM YCBD
FY Sep 2025
-$1.6M
FY Sep 2024
-$542.8K
FY Sep 2023
-$4.6M
FY Sep 2022
-$15.7M
FY Sep 2021
-$14.4M
Jun 2026
-$460.2K
Mar 2026
-$728.2K
Dec 2025
-$977.3K
Sep 2025
-$243.6K
Jun 2025
-$705.7K
Mar 2025
-$205.0K
Dec 2024
-$482.3K
Sep 2024
$157.4K
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2023-12-31 (30 months older than the period end); equity 2026-06-30
Debt to equity YCBD
FY Sep 2025
0.00x
FY Sep 2024
0.00x
FY Sep 2023
0.00x
FY Sep 2022
0.00x
FY Sep 2021
0.00x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt YCBD
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
-478,005.67x
FY Sep 2022
-119.27x
FY Sep 2021
-129.32x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-40.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity YCBD
FY Sep 2025
-44.4%
FY Sep 2024
-67.3%
FY Sep 2023
-113.4%
FY Sep 2022
-104.2%
FY Sep 2021
-25.5%
Jun 2026
-40.3%
Mar 2026
-53.4%
Dec 2025
-43.4%
Sep 2025
-44.4%
Jun 2025
-33.1%
Mar 2025
-8.5%
Dec 2024
-61.0%
Sep 2024
-67.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-25.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets YCBD
FY Sep 2025
-19.4%
FY Sep 2024
-27.6%
FY Sep 2023
-80.5%
FY Sep 2022
-84.6%
FY Sep 2021
-19.8%
Jun 2026
-25.1%
Mar 2026
-22.9%
Dec 2025
-20.1%
Sep 2025
-19.4%
Jun 2025
-12.8%
Mar 2025
-1.2%
Dec 2024
-20.2%
Sep 2024
-27.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital YCBD
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-35.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed YCBD
FY Sep 2025
-47.1%
FY Sep 2024
-49.2%
FY Sep 2023
-95.6%
FY Sep 2022
-102.0%
FY Sep 2021
-17.7%
Jun 2026
-35.5%
Mar 2026
-51.7%
Dec 2025
-41.5%
Sep 2025
-47.1%
Jun 2025
-29.2%
Mar 2025
-29.3%
Dec 2024
-40.6%
Sep 2024
-49.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing YCBD
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.0M
market value at close 2026-10-27 on 2026-08-13 shares, plus long-term debt only, 2023-12-31 (30 months older than the period end), minus cash 2026-06-30
Enterprise value YCBD
FY Sep 2025
$8.5M
FY Sep 2024
$11.7M
FY Sep 2023
$21.8M
FY Sep 2022
$4.9B
FY Sep 2021
$42.9B
Jun 2026
$4.9M
Mar 2026
$5.1M
Dec 2025
$9.3M
Sep 2025
$8.5M
Jun 2025
$6.9M
Mar 2025
$9.8M
Dec 2024
$14.6M
Sep 2024
$11.7M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-58.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield YCBD
FY Sep 2025
-15.2%
FY Sep 2024
-3.8%
FY Sep 2023
-19.5%
FY Sep 2022
-0.3%
FY Sep 2021
-0.0%
Jun 2026
-34.1%
Mar 2026
-34.1%
Dec 2025
-16.8%
Sep 2025
-15.2%
Jun 2025
-15.5%
Mar 2025
-2.1%
Dec 2024
-4.4%
Sep 2024
-3.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing YCBD
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
YCBD ranks highest on financial health (99th percentile) and risk and compliance (51st), and lowest on institutional and government (13th), among Consumer Goods peers.
Profitability
14
Inputs
Return on equity-40.3% · 13 pct, sector of 105
Return on assets-25.1% · 18 pct, sector of 124
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-35.5% · 9 pct, sector of 108
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 112
Cash flow to debtno debt to cover
Growth
32
Inputs
Revenue growth, YoY-3.7% · 32 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
13
Inputs
Funds adding, latest quarter8 · 13 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
51
Inputs
Short interest, % of float+5.0% · 46 pct, sector of 159
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+12.0% · 56 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.